Cipla

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE059A01026
  • NSEID: CIPLA
  • BSEID: 500087
INR
1,460.00
-12 (-0.82%)
BSENSE

Aug 10

BSE+NSE Vol: 9.38 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 597145,
    "name": "Cipla",
    "stock_name": "Cipla",
    "full_name": "Cipla Ltd.",
    "name_url": "stocks-analysis/cipla",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,460.00",
    "chg": -12,
    "chgp": "-0.82%",
    "dir": -1,
    "prev_price": "1,472.00",
    "mcapval": "118,927.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 500087,
    "symbol": "CIPLA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE059A01026",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "9.38 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/cipla-597145-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cipla shares rise 3.7% despite Q1 profit fall, brokerages remain cautious",
        "link": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNQUcwemNUYjBTTm5TczIxN0czcDE3MzdDODF2SnZDejN5QWZneEZFS1ZHbmFEQ0JvLWxXQUVhWU9YSUI1NGRDMnkydXZaVDVRa3QwT3gySmE1X0xEQktFbF9tQjdkY2pUN1JuQ2dLWTJBaHBkUllud3JuZG84WnJfV1BPTWlNSjktRmhrWDBHaVVBejh3Q3R2QWpfUG55MkI3Wlc4NU1obGFqUXVGaEx5Y01lQTloeHg2d0JpTy1Uelk1Ri1UdnJLR0NqSEJfOHBPa0ttd1MwZGlqeF9rTlU1Ykc5OA?oc=5",
        "imagepath": "",
        "date": "2026-07-24 10:21:42",
        "description": "Cipla shares rise 3.7% despite Q1 profit fall, brokerages remain cautious  BusinessLine..."
      },
      {
        "title": "Cipla\\'s Q1 net falls 39% on US business; maintains FY27 margin guidance",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-23 17:57:21",
        "description": "Cipla\\'s Q1 net falls 39% on US business; maintains FY27 margin guidance  Business Standard..."
      },
      {
        "title": "Board of Cipla approves change in senior management",
        "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQYWZxdV9ZWlFJeWV5bkRJMEM1WElsWnk2UkhDSVpHMEZwTWctd256UVJpMEtUM3RjTnhjVzdJSlZXdU44S3lGZ1RaLUdrbXhaYmNEa0owbHc2QkhuaWZ3bjJhczB0MGhfMGE4eHItd0xqM2dUcWx2dFVXX1NCZkRPWnA4Vnl5NW1MS1p1V213NTU2QUJZMUh6NjNxYU1XdURncEdHSmRJRHNfTy1JZEVqVWxpLXpRRFdhS3dwcjJUM3I0eExyN1JDYnMzcHV4QdIB0wFBVV95cUxNMVRDYlJzRGdrS0pBZGZjdlVXbF83S2NNekxlU04wZnF6b0FHcFRyVzQ3VEdVV3o3aThmdTNEbUxTendvVmJqaXg2bDVvWDhobE1ZV1BjRlNyQ085bmt6RWJMOXZjRGlUTGRnUHNOQzByWVFTdk9peldlWS1XTDBkZi12eHN6cVBmRzhpWDRQSnFGd0w4dzN2cmxic3R6OWYxd0VJdzVBblZkdmdXSnpvb2tYQXhvNXR6YjNUWm1TcUhSY1pSOHJmR0x4Q1JUX210cjNZ?oc=5",
        "imagepath": "",
        "date": "2026-07-23 15:16:54",
        "description": "Board of Cipla approves change in senior management  Business Standard..."
      },
      {
        "title": "Cipla Q1 results: Profit falls 39% YoY to 789 crore; revenue climbs 3.50%",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-23 14:09:16",
        "description": "Cipla Q1 results: Profit falls 39% YoY to 789 crore; revenue climbs 3.50%  livemint.com..."
      },
      {
        "title": "Stocks making the biggest moves midday: Cipla, Eternal, Dr Reddys, Waaree Renewable and more",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-23 13:45:45",
        "description": "Stocks making the biggest moves midday: Cipla, Eternal, Dr Reddys, Waaree Renewable and more  financialexpress.com..."
      },
      {
        "title": "Cipla drops after Q1 PAT tumbles 39% YoY to Rs 789 cr",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-23 13:31:26",
        "description": "Cipla drops after Q1 PAT tumbles 39% YoY to Rs 789 cr  Business Standard..."
      },
      {
        "title": "Cipla consolidated net profit declines 39.19% in the June 2026 quarter",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-23 12:55:06",
        "description": "Cipla consolidated net profit declines 39.19% in the June 2026 quarter  Business Standard..."
      },
      {
        "title": "Cipla Q1 net profit falls 39% to 789 crore as expenses rise nearly 15%",
        "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNZzVwdHdwWjd2LUlmZnZreTNobEF6UVFHRVJJRXVuU3VBN0t3U2tIRHFUZ2JkLUlJQ0hCLV8tVEl1SlBMSzRyaENyaFJodVVESTZRQU1tWWkzQ1dJaE5CckJVdUpMNTF0czNvek10dzZlSU1hM1dUM0VXNHBFdHZWVElXVldlZVF5ODhpQUVXdi1CMnpXNW9aREljaWE3NXkwUXpVdG9xX1h2REJTTEk2ZTZGbUQwUUJQaDNFSTRmdWIwTm_SAcgBQVVfeXFMT3l0MUV5c2ZINnB5LWZ5UTE4UDFZM1NXV2hibE56R2VmeVBrRlI1STlteGViNjZ6b3NGQlo5RDVWaDhoYm5YdDcxNmdLdVBQUnNweVczY2R6d0toNk01OHdkVXNWMjFfTHNvalJVWl9GVVY0M1NEVVVNRS1fc2xLRUQ4LVV1X1NHTDhrZktSR0lld3RIMTlaQXg4QzZHXzhHbTNpUGxQdktzc1ZPTkYydXdZWktUNS1jUE96aExCU0ZCQ3RkZDI4R2w?oc=5",
        "imagepath": "",
        "date": "2026-07-23 12:31:44",
        "description": "Cipla Q1 net profit falls 39% to 789 crore as expenses rise nearly 15%  Business Standard..."
      },
      {
        "title": "India\\'s Cipla posts another profit decline, names insider Dinesh Jain CFO",
        "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPT01XYjB2V1FQdV81ZU5ONGNQWFJ3SXV1UlQyUFBZaVVTMjNYV3FnVElzVUd4aHdVWFpZU0ZFWGpVX2pwMVpFN1Q3elJaRG5CMTFkVjJRUVNBQ1Etd2FNYWxJeTY0QUhjdTAwRkdUWFM5RVdfOFRreW1oOHpnMG5zSTNudF8yZmJvMVBPTFJ2MTB4Y2RvVmc2cURrRS0yY2k2NTJZckd5a2gwM3l1X21NTlJNcFlWUW9UYXZtbUtPRQ?oc=5",
        "imagepath": "",
        "date": "2026-07-23 12:10:00",
        "description": "India\\'s Cipla posts another profit decline, names insider Dinesh Jain CFO  Reuters..."
      }
    ],
    "total": 19,
    "sid": "597145",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/cipla-597145"
  },
  "announcements": [
    {
      "caption": "Update On USFDA Inspection At Invagen Manufacturing Facility In Hauppauge Long Island New York USA",
      "datetime": "04-Aug-2026",
      "details": "Please find enclosed intimation.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "31-Jul-2026",
      "details": "In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirments) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 31st July 2026 has allotted 7850 fully paid up equity shares of INR 2 each pursuant to exercise of employee stock options/ stock appreciation rights under the Cipla ESOP Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Cipla Receives U.S. FDA Approval For Generic Advair Diskus®",
      "datetime": "27-Jul-2026",
      "details": "Please find enclosed disclosure",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has declared <strong>650%</strong> dividend, ex-date: 05 Jun 26",
          "dt": "2026-06-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has announced <strong>3:2</strong> bonus issue, ex-date: 24 Apr 06",
          "dt": "2006-04-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Update On USFDA Inspection At Invagen Manufacturing Facility In Hauppauge Long Island New York USA

04-Aug-2026 | Source : BSE

Please find enclosed intimation.

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

31-Jul-2026 | Source : BSE

In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirments) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 31st July 2026 has allotted 7850 fully paid up equity shares of INR 2 each pursuant to exercise of employee stock options/ stock appreciation rights under the Cipla ESOP Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.

Cipla Receives U.S. FDA Approval For Generic Advair Diskus®

27-Jul-2026 | Source : BSE

Please find enclosed disclosure

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Cipla Ltd. has declared 650% dividend, ex-date: 05 Jun 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Cipla Ltd. has announced 3:2 bonus issue, ex-date: 24 Apr 06

stock-summary
RIGHTS

No Rights history available